PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Operating Income Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual operating income in 2023 was 3625.13 Billion USD , down -12.88% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly operating income in 2024 Q3 was 45.8 Million USD , down -28.89% from previous quarter.
PT Kalbe Farma Tbk. reported an annual operating income of 268.06 Million USD in 2022, down -3.76% from previous year.
PT Kalbe Farma Tbk. reported an annual operating income of 278.52 Million USD in 2021, up 11.65% from previous year.
PT Kalbe Farma Tbk. reported a quarterly operating income of 45.8 Million USD for 2024 Q3, down -28.89% from previous quarter.
PT Kalbe Farma Tbk. reported a quarterly operating income of 76.28 Million USD for 2024 Q1, up 22.12% from previous quarter.

Annual Operating Income Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Operating Income of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	3625.13 Billion USD	-12.88%
2022	268.06 Million USD	-3.76%
2021	278.52 Million USD	11.65%
2020	249.45 Million USD	5.44%
2019	236.58 Million USD	7.48%
2018	220.11 Million USD	-5.13%
2017	232.02 Million USD	5.03%
2016	220.9 Million USD	18.87%
2015	185.83 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	64.41 Million USD	-15.56%
2024 Q3	45.8 Million USD	-28.89%
2024 Q1	76.28 Million USD	22.12%
2023 Q4	62.47 Million USD	41.56%
2023 FY	233.53 Million USD	-12.88%
2023 Q1	73.15 Million USD	1.38%
2023 Q2	56.57 Million USD	-22.67%
2023 Q3	44.13 Million USD	-22.0%
2022 Q2	64.75 Million USD	-10.04%
2022 FY	268.06 Million USD	-3.76%
2022 Q4	72.16 Million USD	4.5%
2022 Q3	69.05 Million USD	6.65%
2022 Q1	71.97 Million USD	-11.48%
2021 Q1	61.15 Million USD	0.0%
2021 FY	278.52 Million USD	11.65%
2021 Q4	81.31 Million USD	16.93%
2021 Q3	69.54 Million USD	7.79%
2021 Q2	64.51 Million USD	5.49%
2020 FY	249.45 Million USD	5.44%
2019 FY	236.58 Million USD	7.48%
2018 FY	220.11 Million USD	-5.13%
2017 FY	232.02 Million USD	5.03%
2016 FY	220.9 Million USD	18.87%
2015 FY	185.83 Million USD	0.0%

Peer Operating Income Comparison of PT Kalbe Farma Tbk.

Name	Operating Income	Operating Income Difference
AstraZeneca PLC	8.19 Billion USD	-44146.76%
Bristol-Myers Squibb Company PFD CONV 2	17.24 Billion USD	-20925.038%
CSPC Pharmaceutical Group Limited	7.01 Billion USD	-51569.489%
Clarus Therapeutics Holdings, Inc.	-39.73 Million USD	9124073.193%
Novartis AG	9.76 Billion USD	-37008.578%